Nova Patents
PL3283524T3

Bispecific antibody constructs for cdh3 and cd3

Abstract

This record has no abstract on file.

Term

9.6 yearsto projected expiry

Projected expiry 18 April 2036, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

44 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
15164154European Patent Office (EPO)A
2016058482European Patent Office (EPO)W

Members44

Family members, oldest first
DocumentOfficeKind
CA2982682A1CanadaA1
WO2016166360A1World Intellectual Property Organization (WIPO)A1
TW201704264ATaiwan Province of ChinaA
AR104309A1ArgentinaA1
AU2016250023A1AustraliaA1
SG11201708438WASingaporeA
IL255076A0IsraelA0
IL255076D0IsraelD0
EP3283524A1European Patent Office (EPO)A1
CN107750255AChinaA
KR20180023892ARepublic of KoreaA
CL2017002641A1ChileA1
JP2018512860AJapanA
US2018142021A1United States of AmericaA1
EA201792193A1Eurasian Patent Organization (EAPO)A1
BR112017022326A2BrazilA2
MX2017013348AMexicoA
MA43197AMoroccoA
SG10201909308XASingaporeA
US11028171B2United States of AmericaB2
JP6907124B2JapanB2
AU2016250023B2AustraliaB2
AU2022203450A1AustraliaA1
TWI772258BTaiwan Province of ChinaB
CN107750255BChinaB
US2023041876A1United States of AmericaA1
TW202311292ATaiwan Province of ChinaA
EP3283524B1European Patent Office (EPO)B1
CN116063541AChinaA
FI3283524T3FinlandT3
LT3283524TLithuaniaT
DK3283524T3DenmarkT3
IL255076B1IsraelB1
PT3283524TPortugalT
PL3283524T3This recordPolandT3
ES2945313T3SpainT3
SI3283524T1SloveniaT1
HUE061730T2HungaryT2
IL255076B2IsraelB2
EP4276116A2European Patent Office (EPO)A2
EP4276116A3European Patent Office (EPO)A3
US11926666B2United States of AmericaB2
TWI858372BTaiwan Province of ChinaB
US2025092133A1United States of AmericaA1